---
title: "OrganaBio: The Supply Brain | Uncategorized"
description: Uncategorized |
---

[![OrganaBio-logo-rev-white-copy](https://blog.organabio.com/hs-fs/hubfs/OrganaBio-logo-rev-white-copy.png?width=979&height=239&name=OrganaBio-logo-rev-white-copy.png "OrganaBio-logo-rev-white-copy")](https://www.organabio.com)

![brain](https://blog.organabio.com/hubfs/marketing/brain.png "brain")

# The Supply Brain

Addressing supply chain challenges in cell and gene therapy.

The OrganaBio Blog

## [Developing a Robust CGT Manufacturing Process](https://blog.organabio.com/en/uncategorized/developing-a-robust-cgt-manufacturing-process)

 Posted by [Priya Baraniak, Ph.D.](https://blog.organabio.com/en/author/priyab) on October 28, 2020

- [Tweet](https://twitter.com/share)

In this presentation, OrganaBio's Head of Process & Product Development highlights our approach to setting the stage early in process development for sustained manufacturing success. This talk was originally given at the 2020 Cell & Gene Therapy Bioprocessing & Commercialization global conference. The conference brought together 856 members of the cell and gene therapy community in an effort to stimulate collaborations and partnerships that accelerate the development of life-saving or life-altering therapies for patients in need.

[Read More](https://blog.organabio.com/en/uncategorized/developing-a-robust-cgt-manufacturing-process)

 0 Comments **//** [View or add comments](https://blog.organabio.com/en/uncategorized/developing-a-robust-cgt-manufacturing-process#comments-listing)

 Topics: [Allogeneic Cell Therapy](https://blog.organabio.com/en/tag/allogeneic-cell-therapy), [cGMP Manufacturing](https://blog.organabio.com/en/tag/cgmp-manufacturing-of-cell-and-gene-therapies), [Uncategorized](https://blog.organabio.com/en/tag/uncategorized)

[All posts](https://blog.organabio.com/en/all)

Add a Comment

### Recent Posts

### Posts by Tag

- [Allogeneic Cell Therapy (7)](https://blog.organabio.com/en/tag/allogeneic-cell-therapy)
- [Immune Cells (4)](https://blog.organabio.com/en/tag/immune-cells)
- [MSCs (4)](https://blog.organabio.com/en/tag/mscs)
- [OrganaBio (3)](https://blog.organabio.com/en/tag/organabio)
- [covid-19 (3)](https://blog.organabio.com/en/tag/covid-19)
- [Hematopoietic Stem Cells (2)](https://blog.organabio.com/en/tag/hematopoietic-stem-cells)
- [B cells (1)](https://blog.organabio.com/en/tag/b-cells)
- [Exosomes (1)](https://blog.organabio.com/en/tag/exosomes)
- [Gene Editing (1)](https://blog.organabio.com/en/tag/gene-editing)
- [Immunotherapy (1)](https://blog.organabio.com/en/tag/immunotherapy)
- [NK cells (1)](https://blog.organabio.com/en/tag/nk-cells)
- [Starting Materials (1)](https://blog.organabio.com/en/tag/starting-materials-cell-gene-therapy)
- [T cells (1)](https://blog.organabio.com/en/tag/t-cells)
- [Uncategorized (1)](https://blog.organabio.com/en/tag/uncategorized)
- [cGMP Manufacturing (1)](https://blog.organabio.com/en/tag/cgmp-manufacturing-of-cell-and-gene-therapies)
- [donor variability (1)](https://blog.organabio.com/en/tag/donor-variability)
- [iPSCs (1)](https://blog.organabio.com/en/tag/ipscs)
- [immunomodulation (1)](https://blog.organabio.com/en/tag/immunomodulation)
- [mesenchymal stromal cells (1)](https://blog.organabio.com/en/tag/mesenchymal-stromal-cells)
- [supply chain (1)](https://blog.organabio.com/en/tag/supply-chain)

See all